ADMA Biologics, Inc. (ADMA)
NASDAQ·Healthcare·Biotechnology
$8.95
+2.35%
Mkt Cap $2.04B
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (10 analysts)
$18.67
Range $17.00 – $21.00
Implied Upside
+108.7%
Consensus $18.67 vs current $8.95
NASDAQ·Healthcare·Biotechnology
$8.95
+2.35%
Mkt Cap $2.04B
Buy
4
Hold
1
Sell
0
Price Target (10 analysts)
$18.67
Range $17.00 – $21.00
+108.7%
Consensus $18.67 vs current $8.95